BELLUS Health Inc. (BLUSF)

[BYUINSDER]

I think Neurochem Inc. has "The right people" on their team.

In the transformation process from RD to Product driven enterprise its not just having people on your team..its having the right people....in place.

Kiacta drug and the Alzhemed (Tramiprosate) drug are their two best bets.

The FDA shot them down now.....

How driven is Neurochem team members in getting the test results to fit the FDA requirements?

In the conference call, Most mutual funds were kinda upset I think....that Neurochem Inc. advisory team members didt have the right answers for their questions.

The tone of the call was very negative....

MRI scans test results need to be review by Neurochem Inc. team members..

Can Neurochem team members come up with answers to solve the grid lock with FDA?

One team member spoke out and said "We have options"

Those options better be positive ones..

Or the current burn rate will take away Neurochem Cash..

No cash...no more game time...

I don't see his stock rising UNTIL Neurochem team members give the public something good in way of news..

Kiacta is their bet...